These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 13994748)

  • 1. Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.
    TULLY JG; CURRIE JA
    J Bacteriol; 1962 Oct; 84(4):747-53. PubMed ID: 13994748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.
    GAINES S; LANDY M; EDSALL G; MANDEL AD; TRAPANI RJ; BENENSON AS
    J Exp Med; 1961 Sep; 114(3):327-42. PubMed ID: 13702952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DETECTION AND PERSISTENCE OF VI ANTIGEN IN TISSUES OF ACTIVELY IMMUNIZED MICE.
    GAINES S; CURRIE JA; TULLY JG
    J Bacteriol; 1965 Mar; 89(3):776-81. PubMed ID: 14273660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids.
    Diena BB; Johnson EM; Baron LS; Wallace R; Greenberg L
    Infect Immun; 1973 Jan; 7(1):5-8. PubMed ID: 4120357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attempts to induce typhoid fever in chimpanzees with non-VI strains of Salmonella typhosa.
    TULLY JG; GAINES S; TIGERTT WD
    J Infect Dis; 1962; 110():47-54. PubMed ID: 13923053
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of typhoid antigens in protection and pathogenicity for mice.
    Diena BB; Baron LS; Johnson EM; Wallace R; Ashton FE
    Infect Immun; 1974 Jun; 9(6):1102-4. PubMed ID: 4598256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
    Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
    Diena BB; Ryan A; Wallace R; Ashton FE; Johnson EM; Baron LS
    Infect Immun; 1975 Dec; 12(6):1470-1. PubMed ID: 1107227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting Formation of Incomplete Vi Antibody in Mice.
    Gaines S; Currie JA; Tully JG
    J Bacteriol; 1965 Sep; 90(3):635-42. PubMed ID: 16562060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiments with Vi-negative strains of Salmonella typhi.
    STANDFAST AF
    Bull World Health Organ; 1960; 23(1):47-52. PubMed ID: 13833749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vi-antigen as a criterion in selection of Salmonella typhosa for production of vaccines and its significance of virulence and immunogenesis in typhoid cultures].
    GINTSE LA
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Feb; 29(2):109-10. PubMed ID: 13570416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Live enteric typhoid vaccine consisting of a Vi-negative double-dependent mutant of S. typhi and a Vi-positive strain of Citrobacter].
    Pershin BB; Shuster BIu; Maganet LS; Tolcheev IuD
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):35-40. PubMed ID: 60853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PREVENTIVE PROPERTIES OF SERA OF RABBITS IMMUNIZED WITH VACCINES PREPARED FROM LEVOMYCETIN-RESISTANT TYPHOID BACTERIA].
    GNETEV AM
    Antibiotiki; 1964 Jun; 9():524-8. PubMed ID: 14222465
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological response of the rabbit to Vi antigen.
    Esposito VM; Feeley JC; Leeder WD
    J Bacteriol; 1969 Jul; 99(1):13-7. PubMed ID: 5802598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.
    Wong KH; Feeley JC; Northrup RS; Forlines ME
    Infect Immun; 1974 Feb; 9(2):348-53. PubMed ID: 4205947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agar plaque formation by mouse spleen cells in response to vaccination with Vi antigen and typhoid vaccines.
    Esposito VM
    J Bacteriol; 1969 Jul; 99(1):356-7. PubMed ID: 5802616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.